Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Monoclonal Human Alveolar Epithelial Cell Line (“Arlo”) with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections
Patrick Carius, Annemarie Jungmann, Marco Bechtel, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 12

Showing 12 citing articles:

Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters
Liuhan Dong, Xiaomei Zhuang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4671-4671
Open Access | Times Cited: 6
A Novel In Vitro Primary Human Alveolar Model (AlveolAir™) for H1N1 and SARS-CoV-2 Infection and Antiviral Screening
Cristiane Lopes, Emilie Laurent, Mireille Caul-Futy, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 572-572
Open Access
The effects of fine particulate matter (SRM 2786) on three different 3D lung models exposed at the air-liquid interface – A comparative study
Vegard Sæter Grytting, Tonje Skuland, Jarle Ballangby, et al.
Toxicology in Vitro (2024) Vol. 98, pp. 105841-105841
Open Access | Times Cited: 4
Review of New Approach Methodologies for Application in Risk Assessment of Nanoparticles in the Food and Feed Sector: Status and Challenges
Shirin M. Usmani, Susanne Bremer‐Hoffmann, Karlien Cheyns, et al.
EFSA Supporting Publications (2024) Vol. 21, Iss. 9
Open Access | Times Cited: 4
Characterization of Commercially Available Human Primary Alveolar Epithelial Cells
Christopher Herbst, Elena López-Rodríguez, Vladimir Gluhovic, et al.
American Journal of Respiratory Cell and Molecular Biology (2024) Vol. 70, Iss. 5, pp. 339-350
Closed Access | Times Cited: 2
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays
Santhni Subramaniam, Paul Joyce, Abiodun D. Ogunniyi, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 2, pp. 337-349
Closed Access | Times Cited: 2
Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities
Christopher C. Leon, Eugene Manley, Aaron M. Neely, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Cell-based in vitro models for pulmonary permeability studies
Clémentine Richter, Tobias Neu, Lorenz Latta, et al.
Elsevier eBooks (2024), pp. 137-168
Closed Access
Correlation between cell- and tissue-based in vitro models for drug permeability screening with in vivo situation: modeling and functional extrapolation
Paulo Paixão, Luís F. Gouveia, José Morais, et al.
Elsevier eBooks (2024), pp. 641-663
Closed Access
A stretchable human lung‐on‐chip model of alveolar inflammation for evaluating anti‐inflammatory drug response
Clémentine Richter, Lorenz Latta, Daria Harig, et al.
Bioengineering & Translational Medicine (2024) Vol. 10, Iss. 1
Open Access
Abstracts from The International Society for Aerosols in Medicine
Olivier Reynard, Mathieu Iampietro, Claire Dumont, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery (2023) Vol. 36, Iss. 6, pp. A-39
Open Access | Times Cited: 1
Page 1

Scroll to top